2021 ANNUAL REPORT

Bayer Acquires AskBio

Bayer AG agreed to acquire Asklepolos, a U.S.- headquartered biopharmaceutical company specializing in the research, development and manufacturing of gene therapies across different therapeutic areas.

374

INVENTIONS DISCLOSED

An inventor’s first step in the commercialization process

NEW START-UP: Mente

Mente is developing a surgical instruments tracking system for the operating room which creates dependable, real-time data streams with predictive analytics to transform operating room resource management.

Xilis Raises $70 Million

The North Carolina-based company announced a $70 million Series A funding on Thursday in a round led by Mubadala Capital.

13

This year we’ve helped grow and develop ventures ranging from cancer therapeutics to digital health tools.

Phitonex Acquired by ThermoFisher

Thermo Fisher Scientific announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company.

January 31-February 4
Duke Research Week 2022

Join us virtually for this week-long celebration of research including an exciting array of faculty lectures and panel discussions; graduate student, trainee, and postdoctoral fellow flash talks; and special guest speakers presenting the Robert J. Lefkowitz, MD, Distinguished Lecture and Daubechies Lecture 2022.

Sponsored by the Office of Research and Innovation and Duke University School of Medicine.

118

AGREEMENTS

NEW START-UP:
Replicate Bioscience

Replicate Bioscience is developing RNA-based treatments for cancer using proprietary Synthetic Replicon for gene delivery (SynRGY) technology to deliver the genetic code of a virally derived RNA molecule.

NEW START-UP:
Sparta Biomedical

Sparta Biomedical is a developer of orthopedic solutions. The company’s SBM-01 Biomimetic Implant has been granted a Breakthrough Device Designation from the FDA.

IonQ and Evolv go public

$91M

IN REVENUE